TP53 and colorectal carcinoma: Among the carcinogenic pathways, enrichment of the p53 signaling pathway was found in both type II CRC [FDR adjusted p=0.013, Log2(FC)=1.51] and type II adenoma [FDR adjusted p=0.045, Log2(FC)=0.59] subgroups (Supplementary file Table 14).